Indium In-111 pentetate

DB09425ApprovedInvestigationalSmall moleculeRadioactive Diagnostic Agent

Indium In-111 pentetate is a radiopharmaceutical diagnostic agent used for radionuclide cisternography. Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column.

Mechanism: Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column.
Curator reviewed
Primary indication: Pentetate Indium Disodium In 111 is recommended for use in radionuclide cisternography.Curator reviewed · 1 structured indication
Formula / weight: C₁₄H₂₀InN₃O₁₀ · 501.23 g/mol (avg)
First approval: United States, 1982
Also known as: Indium In 111 pentetate
Brand names: Indium DTPA In 111

Resolves to

Compound

UNII5K3UP561AXCAS135998-32-2PubChem131704319KEGGD04527

Clinical / RWD

ATCV09AX01

Structure

InChIKeyBLALCKLYSDDAOC-JWFOFJTQSA-KSMILES[111In+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)CC(O)=O

What you can answer from here — as of September 17, 2026

2Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

2Marketed productsAcross 1 country and 2 labellers

1ATC codeIncluding every combination product, plus 4 drug categories

Which other approved drugs treat the same conditions as Indium In-111 pentetate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account